Brian McNabb, MD
Assoc Clinical Prof VOL
Medicine
School of Medicine

Publications (8)

Top publication keywords:
Femur NeckCarbamatesAlendronateLumbar VertebraeUridine MonophosphateHepacivirusHepatitis C, ChronicAntiviral AgentsHeterocyclic Compounds, 4 or More RingsOsteoporosis, PostmenopausalOsteoporotic FracturesBone Density Conservation AgentsBone DensitySofosbuvirRibavirin

• Comparison of BMD Changes and Bone Formation Marker Levels 3 Years After Bisphosphonate Discontinuation: FLEX and HORIZON-PFT Extension I Trials.
  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019 Kim TY, Bauer DC, McNabb BL, Schafer AL, Cosman F, Black DM, Eastell R
• Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.
  Hepatology international 2018 Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM…
• Efficacy of Sofosbuvir and Velpatasvir, With and Without Ribavirin, in Patients With Hepatitis C Virus Genotype 3 Infection and Cirrhosis.
  Gastroenterology 2018 Esteban R, Pineda JA, Calleja JL, Casado M, Rodríguez M, Turnes J, Morano Amado LE, Morillas RM, Forns X, Pascasio Acevedo JM, Andrade RJ, Rivero A, Carrión JA, Lens S, Riveiro-Barciela M, McNabb B, …
• Sofosbuvir/velpatasvir for 12 weeks in genotype 1-4 HCV-infected liver transplant recipients.
  Journal of hepatology 2018 Agarwal K, Castells L, Müllhaupt B, Rosenberg WMC, McNabb B, Arterburn S, Camus G, McNally J, Stamm LM, Brainard DM, Mani Subramanian G, Mariño Z, Dufour JF, Forns X
• Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study.
  Hepatology international 2018 Wei L, Xie Q, Hou JL, Tang H, Ning Q, Cheng J, Nan Y, Zhang L, Li J, Jiang J, McNabb B, Zhang F, Camus G, Mo H, Osinusi A, Brainard DM, Gong G, Mou Z, Wu S, Wang G, Hu P, Gao Y, Jia J, Duan Z
• A model of BMD changes after alendronate discontinuation to guide postalendronate BMD monitoring.
  The Journal of clinical endocrinology and metabolism 2014 McNabb B, Vittinghoff E, Eastell R, Schwartz AV, Bauer DC, Ensrud K, Barrett-Connor E, Black DM
• BMD changes and predictors of increased bone loss in postmenopausal women after a 5-year course of alendronate.
  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2013 McNabb BL, Vittinghoff E, Schwartz AV, Eastell R, Bauer DC, Ensrud K, Rosenberg E, Santora A, Barrett-Connor E, Black DM
• Acute liver failure with thyrotoxicosis treated with liver transplantation.
  Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2013 Cascino MD, McNabb B, Gardner DG, Woeber KA, Fox AN, Wang B, Fix OK